These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16998297)

  • 41. Combination pegylated interferon and ribavirin therapy precipitating acute renal failure and exacerbating IgA nephropathy.
    Gordon A; Menahem S; Mitchell J; Jenkins P; Dowling J; Roberts SK
    Nephrol Dial Transplant; 2004 Aug; 19(8):2155. PubMed ID: 15252182
    [No Abstract]   [Full Text] [Related]  

  • 42. Occurrence of diffuse, poorly differentiated hepatocellular carcinoma during pegylated interferon plus ribavirin combination therapy for chronic hepatitis C.
    Capanni M; Lorefice E; Benini MC; Biagini MR; Tozzi A; Salvadori E; Colagrande S; Surrenti C; Milani S
    J Chemother; 2008 Jun; 20(3):380-4. PubMed ID: 18606596
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recurrent myocardial ischaemia during combination antiviral therapy in a patient with chronic hepatitis C and normal aminotransferase levels.
    Lenci I; Piccolo P; Francioso S; Di Paolo D; Galante A; Angelico M
    Dig Liver Dis; 2008 Sep; 40(9):785-90. PubMed ID: 17913610
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thyrotoxic periodic paralysis induced by pegylated interferon alpha plus ribavirin for chronic hepatitis C.
    Yang WS; Chu PL; Liu CH; Chung GB; Wu KD
    J Clin Gastroenterol; 2008 Jan; 42(1):112-3. PubMed ID: 18097301
    [No Abstract]   [Full Text] [Related]  

  • 45. Generalized nummular eczema secondary to peginterferon Alfa-2b and ribavirin combination therapy for hepatitis C infection.
    Shen Y; Pielop J; Hsu S
    Arch Dermatol; 2005 Jan; 141(1):102-3. PubMed ID: 15655158
    [No Abstract]   [Full Text] [Related]  

  • 46. [Acute pancreatitis in a hepatitis C positive patient following treatment with peginterferon alfa-2b and ribavirin].
    Kok KF; de Vries RA
    Ned Tijdschr Geneeskd; 2006 Mar; 150(12):681-3. PubMed ID: 16613253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Bilateral non-arteritic ischemic optic neuropathy during treatment of viral hepatitis C with pegylated interferon and Ribavirin].
    Iferkhass S; Elasri F; Chatioui S; Khoyaali A; Bargach T; Reda K; Oubaaz A
    J Fr Ophtalmol; 2015 Jan; 38(1):34-40. PubMed ID: 25533994
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simeprevir with peginterferon and ribavirin induced interstitial pneumonitis: first case report.
    Tamaki K; Okubo A
    World J Gastroenterol; 2015 Jan; 21(3):1009-13. PubMed ID: 25624738
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bone marrow toxicity in HCV genotype 5a-infected patient after peg-IFN alpha-2a and ribavirin therapy.
    Drapeau CM; Remotti D; Noto P; Capone A; Boumis E; Petrosillo N
    J Chemother; 2008 Oct; 20(5):648-51. PubMed ID: 19028630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rheumatoid arthritis following PEG-interferon-alfa-2a plus ribavirin treatment for chronic hepatitis C: a case report and review of the literature.
    Cacopardo B; Benanti F; Pinzone MR; Nunnari G
    BMC Res Notes; 2013 Oct; 6():437. PubMed ID: 24171974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Generalized eczema secondary to combined treatment with peginterferon alfa-2a and ribavirin in a patient with chronic hepatitis from the hepatitis C virus].
    Ruiz de Casas A; García-Bravo B; Camacho F
    Actas Dermosifiliogr; 2005 Mar; 96(2):122-3. PubMed ID: 16476350
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hemolytic anemia during pegylated IFN-alpha2b plus ribavirin treatment for chronic hepatitis C: ribavirin is not always the culprit.
    Gentile I; Viola C; Reynaud L; Borrelli F; Cerini R; Ciampi R; Piazza M; Borgia G
    J Interferon Cytokine Res; 2005 May; 25(5):283-5. PubMed ID: 15871666
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ischemic colitis during pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.
    Leung Y; Urbanski SJ; Schindel L; Myers RP
    Can J Gastroenterol; 2006 Oct; 20(10):661-3. PubMed ID: 17066158
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Erythema annulare centrifugum due to pegylated interferon-α-2a plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection.
    Gönül M; Külcü Çakmak S; Ozcan N; Deniz Oǧuz I; Ozhamam E
    J Cutan Med Surg; 2014; 18(1):65-8. PubMed ID: 24377478
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pyoderma gangrenosum and exacerbation of psoriasis resulting from pegylated interferon alpha and ribavirin treatment of chronic hepatitis C.
    Yurci A; Guven K; Torun E; Gursoy S; Baskol M; Akgun H; Ozbakir O; Yucesoy M
    Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):811-5. PubMed ID: 17700270
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon alpha for chronic hepatitis C virus infection.
    Schreuder TC; Gelderblom HC; Weegink CJ; Hamann D; Reesink HW; Devries JH; Hoekstra JB; Jansen PL
    Liver Int; 2008 Jan; 28(1):39-46. PubMed ID: 18031478
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vitiligo after combination therapy of pegylated interferon-α-2a, ribavirin and vitamin D in a patient with chronic hepatitis C.
    Oiso N; Sato M; Kawada A
    J Dermatol; 2013 Sep; 40(9):772-3. PubMed ID: 23855823
    [No Abstract]   [Full Text] [Related]  

  • 58. Penile paraffinoma developing during treatment with pegylated interferon alfa-2a for chronic hepatitis C virus infection.
    Bachmeyer C; Moguelet P; Gombeaud T; Sbidian E; Aractingi S
    Arch Dermatol; 2011 Oct; 147(10):1232-3. PubMed ID: 22006152
    [No Abstract]   [Full Text] [Related]  

  • 59. Life-threatening thrombocytopenia and nephrotic syndrome due to focal segmental glomerulosclerosis associated with pegylated interferon alpha-2b and ribavirin treatment for hepatitis C.
    Alves Couto C; Costa Faria L; Dias Ribeiro D; de Paula Farah K; de Melo Couto OF; de Abreu Ferrari TC
    Liver Int; 2006 Dec; 26(10):1294-7. PubMed ID: 17105597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report.
    Gamal N; Brodosi L; Misciali C; Patrizi A; Vukatana G; Malavolta N; Bernardi M; Andreone P
    Ann Hepatol; 2014; 13(2):293-6. PubMed ID: 24558223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.